153 related articles for article (PubMed ID: 29721567)
1. The kinetics of dimethylhydroxypyridinone interactions with iron(iii) and the catalysis of iron(iii) ligand exchange reactions: implications for bacterial iron transport and combination chelation therapies.
Harrington JM; Mysore MM; Crumbliss AL
Dalton Trans; 2018 May; 47(20):6954-6964. PubMed ID: 29721567
[TBL] [Abstract][Full Text] [Related]
2. Factors that influence siderophoremediated iron bioavailability: catalysis of interligand iron (III) transfer from ferrioxamine B to EDTA by hydroxamic acids.
Monzyk B; Crumbliss AL
J Inorg Biochem; 1983 Aug; 19(1):19-39. PubMed ID: 6413650
[TBL] [Abstract][Full Text] [Related]
3. Carrier-facilitated bulk liquid membrane transport of iron(III)-siderophore complexes utilizing first coordination sphere recognition.
Wirgau JI; Crumbliss AL
Inorg Chem; 2003 Sep; 42(18):5762-70. PubMed ID: 12950227
[TBL] [Abstract][Full Text] [Related]
4. Tripodal peptide hydroxamates as siderophore models. Iron(III) binding with ligands containing H-(alanyl)n-beta-(N-hydroxy)alanyl strands (n = 1-3) anchored by nitrilotriacetic acid.
Hara Y; Shen L; Tsubouchi A; Akiyama M; Umemoto K
Inorg Chem; 2000 Oct; 39(22):5074-82. PubMed ID: 11233204
[TBL] [Abstract][Full Text] [Related]
5. Ternary complex formation facilitates a redox mechanism for iron release from a siderophore.
Mies KA; Wirgau JI; Crumbliss AL
Biometals; 2006 Apr; 19(2):115-26. PubMed ID: 16718598
[TBL] [Abstract][Full Text] [Related]
6. Coordination chemistry and biology of chelators for the treatment of iron overload disorders.
Bernhardt PV
Dalton Trans; 2007 Aug; (30):3214-20. PubMed ID: 17893764
[TBL] [Abstract][Full Text] [Related]
7. Thermo-FTIR spectroscopic study of the siderophore ferrioxamine B: spectral analysis and stereochemical implications of iron chelation, pH, and temperature.
Siebner-Freibach H; Yariv S; Lapides Y; Hadar Y; Chen Y
J Agric Food Chem; 2005 May; 53(9):3434-43. PubMed ID: 15853384
[TBL] [Abstract][Full Text] [Related]
8. Ferrioxamine B analogues: targeting the FoxA uptake system in the pathogenic Yersinia enterocolitica.
Kornreich-Leshem H; Ziv C; Gumienna-Kontecka E; Arad-Yellin R; Chen Y; Elhabiri M; Albrecht-Gary AM; Hadar Y; Shanzer A
J Am Chem Soc; 2005 Feb; 127(4):1137-45. PubMed ID: 15669853
[TBL] [Abstract][Full Text] [Related]
9. Iron chelators for clinical use.
Tilbrook GS; Hider RC
Met Ions Biol Syst; 1998; 35():691-730. PubMed ID: 9444773
[No Abstract] [Full Text] [Related]
10. Kinetics of iron release from ferric binding protein (FbpA): mechanistic implications in bacterial periplasm-to-cytosol Fe3+ transport.
Dhungana S; Anderson DS; Mietzner TA; Crumbliss AL
Biochemistry; 2005 Jul; 44(28):9606-18. PubMed ID: 16008346
[TBL] [Abstract][Full Text] [Related]
11. Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics.
Liu G; Men P; Kenner GH; Miller SC; Bruenger FW
Nucleosides Nucleotides Nucleic Acids; 2004; 23(3):599-611. PubMed ID: 15113026
[TBL] [Abstract][Full Text] [Related]
12. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
Devanur LD; Evans RW; Evans PJ; Hider RC
Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
[TBL] [Abstract][Full Text] [Related]
13. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
Chua AC; Ingram HA; Raymond KN; Baker E
Eur J Biochem; 2003 Apr; 270(8):1689-98. PubMed ID: 12694182
[TBL] [Abstract][Full Text] [Related]
14. New chelate-forming polymer microspheres carrying dyes as chelators for iron overload.
Denizli A; Salih B; Piskin E
J Biomater Sci Polym Ed; 1998; 9(2):175-87. PubMed ID: 9493844
[TBL] [Abstract][Full Text] [Related]
15. Iron chelation properties of an extracellular siderophore exochelin MN.
Dhungana S; Miller MJ; Dong L; Ratledge C; Crumbliss AL
J Am Chem Soc; 2003 Jun; 125(25):7654-63. PubMed ID: 12812507
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence of iron uptake by the Gram-positive siderophore-shuttle mechanism without iron reduction.
Fukushima T; Allred BE; Raymond KN
ACS Chem Biol; 2014 Sep; 9(9):2092-100. PubMed ID: 25007174
[TBL] [Abstract][Full Text] [Related]
17. Iron(III) complexes of sterically hindered tetradentate monophenolate ligands as functional models for catechol 1,2-dioxygenases: the role of ligand stereoelectronic properties.
Velusamy M; Mayilmurugan R; Palaniandavar M
Inorg Chem; 2004 Oct; 43(20):6284-93. PubMed ID: 15446874
[TBL] [Abstract][Full Text] [Related]
18. Iron chelation properties of an extracellular siderophore exochelin MS.
Dhungana S; Ratledge C; Crumbliss AL
Inorg Chem; 2004 Oct; 43(20):6274-83. PubMed ID: 15446873
[TBL] [Abstract][Full Text] [Related]
19. Iron overload and chelation.
Hershko C; Link G; Konijn AM; Ioav Cabantchik Z
Hematology; 2005; 10 Suppl 1():171-3. PubMed ID: 16188664
[TBL] [Abstract][Full Text] [Related]
20. Reduction of iron by extracellular iron reductases: implications for microbial iron acquisition.
Cowart RE
Arch Biochem Biophys; 2002 Apr; 400(2):273-81. PubMed ID: 12054438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
